BD Intraosseous Needle Recall: FDA Lists 45 Serious-Injury Reports and Four Death Reports

Source status: This is an active nationwide recall. The U.S. Food and Drug Administration posted BD’s company announcement on August 3, 2026. The FDA summary gives July 30 as the company-announcement date. The announcement body is dated July 31. The complaint and outcome counts come from BD and are reproduced by FDA. They do not prove that the recalled device caused every injury or death.

BD is recalling specific lots of five needle-set sizes. Clinicians reported trouble removing the obturator, also called the stylet, after placing a needle. These sets provide fast vascular access during emergencies such as cardiac arrest and severe trauma. A delay in that setting can be dangerous.

The most serious numbers need clear labels. Through June 2026, BD reported 75 complaints, 45 serious-injury reports, and four death reports. The FDA-posted announcement says the four death reports involved trouble removing the stylet. The trouble occurred during attempts to revive people who had cardiac arrests outside a hospital. The notice does not say the needle set was proven to be the sole cause of any death.

What BD recalled

The recall is limited to specified lots of BD Intraosseous Vascular Access System Needle Sets. The affected product families and catalog numbers are:

• 15 mm x 15 gauge: D015151NK
• 25 mm x 15 gauge: D015251NK
• 35 mm x 15 gauge: D015351NK
• 45 mm x 15 gauge: D015451NK
• 55 mm x 15 gauge: D015551NK

BD said the affected lots had dimensions outside tolerance. They were distributed from September 30, 2024, through June 12, 2026. The complete lot and expiration list is in the customer letter linked from the FDA-posted recall announcement. A catalog number alone is not enough. Facilities need to match the catalog number, lot, and expiration date.

What the reported outcomes do and do not prove

The announcement says a stuck obturator may force a clinician to get another needle or use another access method. That can delay care. The notice says the risk is greatest for very ill patients who need urgent access. That includes people in cardiac arrest or with severe trauma.

The four death reports are key public-safety facts. They should not be reduced to a generic device problem. They also should not be turned into an unsupported claim of cause. The notice links trouble removing the stylet to four reports from attempts to revive patients. It does not say what would have happened without the device problem. It also does not rule out other medical factors or announce a final finding on cause.

The same care is needed with the 45 serious-injury reports. They are outcomes reported with complaints in BD’s notice. The public page does not give a story for each patient. It also does not give an independent review of each case or a final recall success rate.

What hospitals and EMS systems should check

BD says it is notifying customers and distributors that may have received the affected lots. The company tells them to stop using covered lots at once. It also tells them to destroy affected needle sets under their facility’s process. Direct BD customers can seek replacements after they return a completed response form.

An internal check should record the product name, catalog number, lot number, expiration date, quantity, and storage site. It should also record when the product was set aside or destroyed and who else was notified. Facilities should use the official lot table and their own recall rules. A headline or social-media screenshot is not enough.

Questions and adverse-event reports can go to BD’s North American Regional Complaint Center. Call 1-844-823-5433, Monday through Friday from 8 a.m. to 5 p.m. Central Time, or email productcomplaints@bd.com. Device problems may also be reported through FDA MedWatch. This article is a recall ledger, not medical advice. Urgent care decisions belong with qualified clinicians and emergency protocols.

Why the powered-driver distinction matters

The FDA-posted announcement says the BD Intraosseous Powered Driver is not affected. The recall covers the specified needle-set lots. This difference matters. A warning that is too broad could remove equipment that is not recalled. A warning that is too narrow could leave a recalled needle set ready for use in an emergency.

BD says its review, bench tests, and clinical observations found two use conditions that may make removal harder. The drill may not be pulled straight back during insertion, or the obturator may be turned the wrong way during removal. BD also says the recalled lots had dimensions outside tolerance. The public notice points to both device dimensions and use conditions. It does not give a simple one-factor explanation.

Accountability questions and the next records step

BD says it found a root cause and took corrective and preventive steps. Those steps include product and label changes. The FDA-posted announcement does not include a final FDA recall class. It also does not give a retrieval rate, a completed-notice rate, or a public closeout finding.

BadPD will monitor the FDA Enforcement Reports and the recall page. We will watch for a final class, changes in scope, corrected lot data, retrieval results, and recall closure. We are not filing a broad records request while the active recall and customer notice process is underway. If key gaps remain later, a narrow request could seek the final class and recall-effectiveness records. It would not seek patient medical files or use a fishing request.

Dated source ledger

• FDA-posted BD intraosseous needle-set recall announcement: FDA summary lists company announcement July 30, 2026; body dateline July 31; FDA publication August 3. Checked August 10, 2026.
• FDA MedWatch: official adverse-event and product-problem reporting route. Checked August 10, 2026.
• FDA Enforcement Reports: official explanation of recall classification and enforcement-report status. Checked August 10, 2026.

Correction and update policy: BadPD separates the existence of a report from proof of causation. If FDA, BD, a court, or another accountable source changes the complaint count, injury count, death-report count, lot scope, classification, or recall status, this ledger will be updated with a dated note.